소아 만성 B형 간염에서 Hepatitis B Virus Precore와 Core Promoter 및 “a” 결정기의 변이종에 대한 연구
Mutations in Hepatitis B Virus Precore, Core Promoter, and “a” Determinant in Children with Chronic Hepatitis B Virus Infection
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose: The aim of this study was to determine the prevalence, types of variants, and clinical significance of mutations in precore, core promoter, and “a” determinant mutations in children with chronic hepatitis B virus infection. Methods: Thirty-one patients with chronic hepatitis B virus infection who visited Seoul National University Children's Hospital in Korea between 2004 and 2005 were enrolled in this study. Serum HBV DNA was amplified by polymerase chain reaction (PCR) and the precore/core promoter and “a” determinant sequences were determined. Results: Precore mutations were found in 11 of 27 patients (40.7%), and appeared more frequently in the HBeAg-negative group (p＜0.05) compared to the HBeAg-positive group. G1896A was detected most frequently (81.8%). BCP mutations were found in 15 of 27 patients (55.6%) and the TA mutation (A1762T/G1764A) was the most common (86.7%). Mutations in the “a” determinant region were detected in 8 of 28 patients (28.6%), and amino acid changes were detected in 6 of 28 patients (21.4%). Of these mutations, substitutions at amino acid position 126 were found most frequently. Conclusion: In children with chronic hepatitis B virus infection, the most common mutations were G1896A in the precore region and TA mutation(A1762T/G1764A) in the core promoter region. Substitutions at amino acid position 126 was the most common mutation in the “a” determinant. Precore mutants were found to be significantly higher in HBeAg-negative patients. The high prevalence of mutations in the “a” determinant and low frequency of G145R were characteristic features. These mutations were not significantly associated with other clinical features except for high aminotransferase concentration in the core promoter variant group. (Korean J Pediatr Gastroenterol Nutr 2011; 14: 279∼285)
Abstract
Purpose: The aim of this study was to determine the prevalence, types of variants, and clinical significance of mutations in precore, core promoter, and “a” determinant mutations in children with chronic hepatitis B virus infection. Methods: Thirty-one patients with chronic hepatitis B virus infection who visited Seoul National University Children's Hospital in Korea between 2004 and 2005 were enrolled in this study. Serum HBV DNA was amplified by polymerase chain reaction (PCR) and the precore/core promoter and “a” determinant sequences were determined. Results: Precore mutations were found in 11 of 27 patients (40.7%), and appeared more frequently in the HBeAg-negative group (p＜0.05) compared to the HBeAg-positive group. G1896A was detected most frequently (81.8%). BCP mutations were found in 15 of 27 patients (55.6%) and the TA mutation (A1762T/G1764A) was the most common (86.7%). Mutations in the “a” determinant region were detected in 8 of 28 patients (28.6%), and amino acid changes were detected in 6 of 28 patients (21.4%). Of these mutations, substitutions at amino acid position 126 were found most frequently. Conclusion: In children with chronic hepatitis B virus infection, the most common mutations were G1896A in the precore region and TA mutation(A1762T/G1764A) in the core promoter region. Substitutions at amino acid position 126 was the most common mutation in the “a” determinant. Precore mutants were found to be significantly higher in HBeAg-negative patients. The high prevalence of mutations in the “a” determinant and low frequency of G145R were characteristic features. These mutations were not significantly associated with other clinical features except for high aminotransferase concentration in the core promoter variant group. (Korean J Pediatr Gastroenterol Nutr 2011; 14: 279∼285)
참고문헌 (15)
- Lin CL, "The clinical implications of hepatitis B virus genotype: Recent advances", J Gastroenterol Hepatol, 26(1), pp.123~130 (2011)
- Liu Y, "Features and clinical implications of hepatitis B virus genotypes and mutations in basal core promoter", precore region in 507 Chinese patients with acute and chronic hepatitis B, 2010, pp.47, 243~247
- Kao JH, "Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers", Gastroenterology, 124, pp.327~334 (2003)
- Zheng JX, "Role of hepatitis B virus base core and precore", core promoter mutations on hepatocellular carcinoma in untreated older genotype C Chinese patients, 2011, pp.18, 423~431
- Carmen WF, "Vaccine- induced escape mutant of hepatitis B virus", Lancet, 336, pp.325~329 (1990)
- Tabor E, "Infections by hepatitis B surface antigen gene mutants in Europe and North America", J Med Virol, 78(1), pp.43~47 (2006)
- Carman WF, "Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection", Lan, 2, pp.588~591 (1989)
- 김진국, "소아 만성 B형 간염에서 Hepatitis B Virus Precore와 Core Promotor 부위의 변이양상에 대한 관찰 - 수직감염과 비수직감염의 비교 관찰", Korean Journal of Pediatrics, 43(6), pp.779~791 (2000), 대한소아과학회
- 강현식, "Precore and Core Promoter Mutations of the Hepatitis B Virus Gene in Chronic Genotype C -Infected Children", Journal of Korean Medical Science, 26(4), pp.546~550 (2011), 대한의학회
- Yang HI, "Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma", J Natl Cancer Inst, 100, pp.1134~1143 (2008)
- Hsu HY, "Survey of hepatitis B surface variant infection in children 15 years after a nationwide vaccination programme in Taiwan", Gut, 53, pp.1499~1503 (2004)
- Ni YH, "Hepatitis B vaccination in children: the Taiwan experience", Pathol Biol, 58, pp.296~300 (2010)
- Zanetti AR, "Hepatitis B variant in Europe", Lancet, 12, pp.1132~1133 (1988)
- Hsu HY, "Survey of hepatitis B surface variant infection in children 15 years after a nationwide vaccination programme in Taiwan", Gut, 53, pp.1499~1503 (2004)
- Song BC, "Prevalence of naturally occurring surface antigen variants of hepatitis B virus in Korean patients infected chronically", J Med Virol, 76, pp.194~202 (2005)